A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer by Trastuzumab intravenous and subcutaneous in day sessions
Oncology
Gynecology
PMSI
article
Auteurs : Cécile Blein, Chantal Bernard-Marty, Véronique Priou, Marie-Claude Borg, Marie-Ange Mouret-Reynier, Gaelle Lebozec, Jean-François Tournamille, Anne Jaffré, Nathalie Perez-staub, Raphael Alfonsi, Nadia Bahmad, Hanane Attar-Rabia
Date de publication : 1 January 2018